ArticleBMC oral health2026
CT and finite element analysis of mandibular advancement device mechanics in a participant with obstructive sleep apnea: a proof-of-concept study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study constructed three-dimensional finite element (3D-FE) models of the upper airway and surrounding structures from spiral computed tomography (CT) data. An optimized fluid-structure interaction (FSI) analysis was applied to investigate the biomechanical effects of the mandibular advancement device (MAD) on peri-airway tissues, refining its therapeutic mechanism in obstructive sleep apnea (OSA).
methodsOne adult patient diagnosed with moderate OSA underwent CT scans in natural sleep before and after 2 months of MAD therapy. 3D-FE models of the upper airway and surrounding structures were constructed from CT data to quantify morphological changes and displacements of the hyoid bone, soft palate, tongue, epiglottis, and the upper airway. FSI analysis was performed to assess airflow pressure and velocity in both the sagittal plane and cross-sections of the upper airway, as well as the displacement of the aforementioned soft tissues, at both peak inspiration and expiration.
resultsMAD-induced mandibular protrusion resulted in anterosuperior displacement of the tongue, soft palate, epiglottis, and hyoid bone, accompanied by shortening of the soft palate and lengthening of the epiglottis. These alterations dilated the upper airway in both sagittal and coronal dimensions, thereby increasing airway volume and minimum cross-sectional area. MAD also reduced and homogenized airflow pressure and velocity in both the sagittal plane and key cross-sections of the upper airway at peak inspiration and expiration, while attenuating the displacement of the pharyngeal wall, tongue, soft palate, and epiglottis, with effects more pronounced at peak inspiration.
conclusionsMAD treats OSA through a synergistic biomechanical mechanism. It enlarges the pharyngeal airway via anterosuperior repositioning of peri-airway tissues. This resultant upper airway dilation attenuates and homogenizes airflow pressure and velocity, thereby stabilizing the pharyngeal wall and peripharyngeal structures, with more pronounced effects during inspiration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.